References
- Smith JK. Factor XI deficiency and its management. Haemophilia 1996;2:128–136.
- Bolton-Maggs PHB. Factor XI deficiency: A review. Haemo-philia 1995;1:217–221.
- Bolton-Maggs PHB, Perry DJ, Chalmers EA, et al. The rare coagulation disorders—review with guidelines for manage-ment from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004;10:593–628.
- Salomon O, Seligsohn U. New observations on factor XI deficiency. Haemophilia 2004;10 (Suppl. 4):184–187.
- Broze GJ Jr, Gailani D. The role of factor XI in coagulation. Thromb Haemost 1993;70:72–74.
- Von dem Borne PAK, Meijers JC, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995;86:3035–3042.
- Hancock JF, Wieland K, Pugh RE, et al. A molecular genetic study of factor XI deficiency. Blood 1991;77:1942–1948.
- Zivelin A, Bauduer F, Ducout L, et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 2002; 99:2448–2454.
- Bolton-Maggs PHB, Peretz H, Butler R, et al. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost 2004;2: 918–924.
- Zadra G, Asselta R, Malcovati M, et al. Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients. Haematologica 2004;89:1332–1340.
- Kravtsov D, Wu W, Meijers JC, et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood 2004;104:128–134.
- Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991;3253:153–158.
- Kadir RA, Economides DL, Lee CA. Factor XI deficiency in women. Am J Hematol 1999;60:48–54.
- Bolton-Maggs PHB. The managment of factor XI deficiency. Haemophilia l998;4:683–688.
- Bolton-Maggs PH, Colvin BT, Satchi BT, Lee CA, Lucas GS. Thrombogenic potential of factor XI concentrate. Lancet 1994;344:748–749.
- Mannucci PM, Bauer KA, Santagostino E, et al. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood 1994;84:1314–1319.
- Berliner S, Horowitz I, Martinowitz U, Brenner B, Seligsohn U. Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coagul Fibrinolysis 1992;3:465–468.
- Cattaneo M. Review of clinical experience of desmopressin in patients with congenital and acquired bleeeding disorders. Eur J Anaesthesiol 1997;14 (Suppl. 14):10–18.
- Castaman G, Ruggeri M, Rodeghiero F. Clinical usefulness of desmopressin for prevention of surgical bleeding in patients with symptomatic heterozygous factor XI deficiency. Br J Hematol 1996;94:168–170.
- Bauduer F, Bendriss P, Freyburger G, Ducout L, Marti B. Use of desmopressin for prophylaxis of surgical bleeding in factor XI-deficient patients. Acta Haematol 1998;99:52–53.
- Franchini M, de Gironcoli M, Lippi G, Manzato F, Aprili G, Gandini G. Prophylactic use of desmopressin in surgery of six patients with symptomatic heterozygous factor XI deficiency. Haematologica 2000;85:106–107.
- Salomon O, Zivelin A, Livnat T, et al. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood 2003;101:4783–4788.
- Lawler P, White B, Pye S, et al. Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency. Haemophilia 2002;8:145–148.